Dedicated to fighting the world's toughest cancer!
Live Last read · last published · next check
Aug 18, 2026 - By Julie Vasquez Every so often, there is a breakthrough in cancer research that changes what people believe is possible. For pancreatic cancer, that moment is now. PanCAN’s Dr. Anna Berkenblit, Cassadie Moravek and Julie Fleshman join a standing ovation after Dr. Brian Wolpin announced the positive results from the RASolute 302 clinical trial of daraxonrasib at the 2026 American…
Aug 17, 2026 - By Erin Post For decades, pancreatic cancer research was defined by what seemed to be impossible. Researchers couldn’t target the mutations in the RAS family of proteins that drive more than 90% of cases. Often described as a “smooth ball,” the RAS protein is frustratingly free of any pockets or divots that would allow a drug to bind to it. Researchers deemed it “undruggable.” Not…
Aug 12, 2026 - By Carly Eskin When Jane Talbot talks about pancreatic cancer , she doesn’t just speak as a volunteer or advocate . She speaks as a wife, a mother, a grandmother and someone who will do anything to end this disease. Her husband, Frank, was diagnosed with pancreatic cancer in 2008. Like so many families, they knew very little about the disease before his diagnosis. What they did know…
Aug 12, 2026 - By Paula Mukherjee Editor’s note: Chicago Advocacy Chair Joanne Zborowski spoke with PanCAN’s Paula Mukherjee about her personal connection to PanCAN’s mission and advice for others who have lost a loved one to pancreatic cancer. Paula: What is your connection to PanCAN’s mission? Joanne and Bill. Joanne: My husband, Bill, was diagnosed with Stage 2B pancreatic cancer in 2019. Both…
Aug 10, 2026 - By Carly Eskin Scientific discovery depends on a research system that is rigorous, transparent and guided by experts. Today, that system is at risk. The administration, through the Office of Management & Budget, has proposed significant changes to how federally funded research projects are reviewed and awarded. While Congress has worked to prioritize and increase funding for…
Jul 23, 2026 - By Carly Eskin Editor’s note: Back in 2018, PanCAN volunteer and advocate Monica Mishra shared her story with the community. Eight years later, Monica is still passionate about ending pancreatic cancer, the disease that took the lives of both of her parents. In honor of National Parents’ Day, we caught up with Monica to see what has changed in those eight years and learn about her…
Jul 9, 2026 - By Carly Eskin NEW — Congress is Listening – Keep Raising Your Voice! Pancreatic cancer advocates are making their voices heard – and Congress is listening. Because of advocates like you across the country, pancreatic cancer research funding is gaining attention at a critical time. Every email sent, every call made and every personal story shared with lawmakers helps raise awareness…
Jul 8, 2026 - By Paula Mukherjee Editor’s Note: Survivor, volunteer and top PurpleStride fundraiser John Walmsley spoke with PanCAN’s Paula Mukherjee about his commitment to providing support to other survivors and passion for fundraising. Paula: What is your connection to PanCAN’s mission? John: It all started in the winter of 2015. I wasn’t feeling like myself. I had no energy. I knew something…
Jul 7, 2026 - By Julie Vasquez The Gift is Part of PanCAN’s $250 Million All Together We Can Campaign to Accelerate Breakthrough Research, Expand Patient Support, and Champion a Thriving Community LOS ANGELES, CALIF. – (July 7, 2026) – The Pancreatic Cancer Action Network (PanCAN) today announced a $500,000 gift from the Paul M. Angell Family Foundation to expand its one-of-a-kind PanCAN Patient…
Jul 1, 2026 - By Charaighn Sesock LOS ANGELES, CALIF. – (July 1, 2026) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, proudly announces new appointments to its Fiscal Year 2027 Board of Directors and Scientific and Medical Advisory Board (SMAB), effective July 1, 2026. Peter Bernstein of Alexander Wolf & Son will be…
